Emmaus Medical
  • CEO Letters
  • Overview
    • Mission
    • Leadership
      • Management Team
      • Board of Directors
    • Corporate Compliance
    • Corporate Governance
  • Products
    • Endari
  • Pipeline
    • Research Publications
    • Diverticulosis
    • Cell Sheet Engineering
  • News
    • Press Releases
    • Media Contacts
    • Media Kit
  • Investors
  • Career
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Pre-merger Emmaus Life Science SEC Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Emmaus Life Sciences Announces Equity Purchase Agreement for up to $25 Million with Lincoln Park Capital

Mar 03, 2020 8:00am EST

Emmaus Life Sciences Reports Preliminary Gross Sales for the Three Months Ended December 31, 2019

Feb 05, 2020 8:00am EST

Emmaus Life Sciences Reports Positive Top-Line Preliminary Results in First Patient in Diverticulosis Pilot Trial

Jan 29, 2020 8:00am EST

Emmaus Life Sciences Expresses Concerns Over Inaccuracies in Draft Report Issued by ICER (Institute for Clinical and Economic Review)

Jan 27, 2020 8:00am EST

Emmaus Life Sciences Announces a New Adherence Program for Its Sickle Cell Disease Patients

Jan 06, 2020 8:00am EST

Emmaus Life Sciences Announces First Purchase Order from its Partnership with taiba Healthcare

Dec 31, 2019 4:01pm EST

Emmaus Life Sciences Announces Update of its Partnership with taiba Healthcare to Expand Patient Access for Sickle Cell Disease Treatment in the Middle East and North Africa (MENA) Region

Dec 23, 2019 4:01pm EST

Emmaus Life Sciences Reports 2019 Third Quarter Financial Results

Nov 12, 2019 8:00am EST

Emmaus Life Sciences Announces Equity Investment from a Corporate Investor

Oct 29, 2019 8:00am EDT

Emmaus Life Sciences Reports Preliminary Gross Sales for the Three Months Ended September 30, 2019

Oct 11, 2019 8:00am EDT
RSS
  • Prev
    • 1...
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • ...15
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    Emmaus Medical, Inc. Registered ® Emmaus Medical, Inc, Torrance, CA. All rights reserved.

    • Privacy
    • Terms of Use
    • Contact